Cite

HARVARD Citation

    Du, J. et al. (2021). Cutaneous toxicity of FDA-approved small-molecule kinase inhibitors. Expert opinion on drug metabolism and toxicology. pp. 1311-1325. [Online]. 
  
Back to record